...
首页> 外文期刊>BMC Molecular Biology >The non-dosage compensated Lsp1α gene of Drosophila melanogaster escapes acetylation by MOF in larval fat body nuclei, but is flanked by two dosage compensated genes
【24h】

The non-dosage compensated Lsp1α gene of Drosophila melanogaster escapes acetylation by MOF in larval fat body nuclei, but is flanked by two dosage compensated genes

机译:果蝇无剂量补偿的Lsp1α基因逃脱了幼虫脂肪体细胞核中MOF的乙酰化作用,但两侧有两个剂量补偿基因

获取原文
           

摘要

Background In Drosophila melanogaster dosage compensation of most X-linked genes is mediated by the male-specific lethal (MSL) complex, which includes MOF. MOF acetylates histone H4 at lysine 16 (H4K16ac). The X-linked Larval serum protein one α (Lsp1α) gene has long been known to be not dosage compensated. Here we have examined possible explanations for why the Lsp1α gene is not dosage compensated. Results Quantitative RNase protection analysis showed that the genes flanking Lsp1α are expressed equally in males and females and confirmed that Lsp1α is not dosage compensated. Unlike control X-linked genes, Lsp1α was not enriched for H4K16ac in the third instar larval fat body, the tissue in which the gene is actively expressed. X-linked Lsp1α promoter-lacZ reporter transgenes are enriched for H4K16ac in third instar larval fat body. An X-linked reporter gene bracketed by Lsp1α flanking regions was dosage compensated. One of the genes flanking Lsp1α is expressed in the same tissue. This gene shows a modest enrichment for H4K16ac but only at the part of the gene most distant from Lsp1α. Phylogenetic analyses of the sequences of the genomes of 12 Drosophila species shows that Lsp1α is only present within the melanogaster subgroup of species. Conclusion Lsp1α is not modified by the MSL complex but is in a region of the X chromosome that is regulated by the MSL complex. The high activity or tissue-specificity of the Lsp1α promoter does not prevent regulation by the MSL complex. The regions flanking Lsp1α do not appear to block access by the MSL complex. Lsp1α appears to have recently evolved within the melanogaster subgroup of Drosophila species. The most likely explanation for why Lsp1α is not dosage compensated is that the gene has not evolved a mechanism to independently recruit the MSL complex, possibly because of its recent evolutionary origin, and because there appears to be a low level of bound MSL complex in a nearby gene that is active in the same tissue.
机译:背景技术在果蝇中,大多数X连锁基因的剂量补偿是由雄性特异性致死(MSL)复合物介导的,其中包括MOF。 MOF在赖氨酸16(H4K16ac)处乙酰化组蛋白H4。 X链接的幼虫血清蛋白一个α(Lsp1α)基因很早就没有剂量补偿。在这里,我们检查了为什么Lsp1α基因没有剂量补偿的可能解释。结果定量RNA酶保护分析表明,Lsp1α侧翼的基因在男性和女性中均表达,并证实Lsp1α没有剂量补偿。与对照X连锁基因不同,Lsp1α在第三龄幼虫脂肪体内(该基因在其中活跃表达的组织)中的H4K16ac并未富集。 X连锁的Lsp1α启动子-lacZ报道基因转基因在第三龄幼虫脂肪体内富集H4K16ac。用剂量补偿补偿由Lsp1α侧翼区包围的X连锁报告基因。 Lsp1α侧翼的基因之一在同一组织中表达。该基因显示出对H4K16ac的适度富集,但仅在该基因中距Lsp1α最远的部分。对12个果蝇物种的基因组序列进行系统进化分析表明,Lsp1α仅存在于黑腹果蝇亚种中。结论Lsp1α不会被MSL复合物修饰,而是位于X染色体的一个受MSL复合物调节的区域。 Lsp1α启动子的高活性或组织特异性不会阻止MSL复合物的调控。 Lsp1α侧翼的区域似乎没有阻止MSL复合体访问。 Lsp1α似乎最近在果蝇种的黑色素瘤亚组内进化。为什么Lsp1α不进行剂量补偿的最可能解释是,该基因没有进化出独立募集MSL复合物的机制,可能是由于其最近的进化起源,以及在一个小分子中结合MSL复合物的水平较低。在同一组织中活跃的附近基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号